Form D · Other Health Care
Dynova Laboratories Inc
Parsippany, NJ · CIK 0001400522
Offering snapshot reported Dec 4, 2009 · SEC filing
- Reported sold
- $15M Offering amount: $25M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 26, 2007 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 4, 2009 | Amendment | $15,000,000 | No comparison | 2 | SEC filing |
| Jun 1, 2009 | Amendment | $11,000,000 | No comparison | Not reported | SEC filing |
| Jul 21, 2008 | Paper | Not reported | No comparison | Not reported | |
| May 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-103294
Source: Form D, filed Dec 4, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Aisling Capital | Promoter |
| N/A Menemsha Capital Partners | Promoter |
| Lynne Millheiser Swanbeck | Director, Executive |
| Dennis Purcell | Director, Executive |
| Andrew Schiff, Md | Director, Executive |
| Anthony Y. Sun, Md | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
160 Littleton Road Suite 201
Parsippany, NJ, 07054
Parsippany, NJ, 07054